by scienc61-ca | Mar 24, 2018 | Article
Despite aggressive treatment changes and screening practices, long term survival in patients with epithelial ovarian cancer (EOC) has remained unchanged in the last 25 years. By Marielle Fares, Pharm. D January 26, 2018- In early-stage and advanced-stage EOC patients,...
by scienc61-ca | Mar 24, 2018 | Article, medical post
Ibrutinib, a Bruton tyrosine kinase (BTK) inhibitor, showed modest efficacy in relapsing or rituximab-refractory follicular lymphoma (FL). By Marielle Fares, Pharm.D January 18, 2018- Patients with rituximab-sensitive FL showed significantly higher response rates to...
by scienc61-ca | Mar 24, 2018 | Article, medical post
Studies of patients treated with SGAs showed a lower prevalence of TD when compared with studies of patients receiving FGAs alone or in combination with SGAs. By Marielle Fares, Pharm.D January 26, 2018- In patients with tardive dyskinesia (TD), treatment with...
by scienc61-ca | Mar 24, 2018 | Article
Clinical and demographic factors differentiate patients with functional (psychogenic) stereotypies (FS) of functional movement disorders (FMDs) from patients with tardive dyskinesia (TD). By Marielle Fares, Pharm.D January 26, 2018- The phenomenology of FS typical of...
